Business Wire
BusinessIntel’s push toward on-prem, privacy-focused AI gets a partnership spotlight as Xeon 6 platform work expandsThe Apex TimesBusinessDICK’S Sporting Goods’ guidance cut rattles NIKE, highlighting how weakness at a key specialty retailer can spreadThe Apex TimesBusinessBroadcom (AVGO) set to report earnings Wednesday after the bell, with investors focused on guidance and demand outlinesThe Apex TimesBusinessApple’s John Ternus steps in as investors weigh a valuation-driven “nearly $5 trillion” challengeThe Apex TimesBusinessSalesforce shares jump 22% after results challenge AI skepticism, CNBC’s Jim Cramer saysThe Apex TimesBusinessSeasonality on Wall Street turns investors’ attention to September, with Nvidia and Micron in focusThe Apex TimesBusinessJim Cramer argues Netflix’s valuation should reflect durability despite leadership shake-upThe Apex TimesBusinessNetflix releases a new trailer and key art for ‘The Fixers,’ previewing covert missions in Taiwan’s temple worldThe Apex TimesBusinessLilly’s $2.88 Billion Immunology Acquisition Moves Into Phase 1 as Lead Program Remains EarlyThe Apex TimesBusinessNvidia’s $3.5 Billion Push Highlights a Broader AI Supply-Chain StrategyThe Apex TimesBusinessTesla shares rise after unveiling a cheaper Model 3 in Hong KongThe Apex TimesBusinessAnthropic signs a $35 billion cloud computing deal tied to Nvidia-backed startupThe Apex TimesBusinessIntel’s push toward on-prem, privacy-focused AI gets a partnership spotlight as Xeon 6 platform work expandsThe Apex TimesBusinessDICK’S Sporting Goods’ guidance cut rattles NIKE, highlighting how weakness at a key specialty retailer can spreadThe Apex TimesBusinessBroadcom (AVGO) set to report earnings Wednesday after the bell, with investors focused on guidance and demand outlinesThe Apex TimesBusinessApple’s John Ternus steps in as investors weigh a valuation-driven “nearly $5 trillion” challengeThe Apex TimesBusinessSalesforce shares jump 22% after results challenge AI skepticism, CNBC’s Jim Cramer saysThe Apex TimesBusinessSeasonality on Wall Street turns investors’ attention to September, with Nvidia and Micron in focusThe Apex TimesBusinessJim Cramer argues Netflix’s valuation should reflect durability despite leadership shake-upThe Apex TimesBusinessNetflix releases a new trailer and key art for ‘The Fixers,’ previewing covert missions in Taiwan’s temple worldThe Apex TimesBusinessLilly’s $2.88 Billion Immunology Acquisition Moves Into Phase 1 as Lead Program Remains EarlyThe Apex TimesBusinessNvidia’s $3.5 Billion Push Highlights a Broader AI Supply-Chain StrategyThe Apex TimesBusinessTesla shares rise after unveiling a cheaper Model 3 in Hong KongThe Apex TimesBusinessAnthropic signs a $35 billion cloud computing deal tied to Nvidia-backed startupThe Apex TimesBusinessIntel’s push toward on-prem, privacy-focused AI gets a partnership spotlight as Xeon 6 platform work expandsThe Apex TimesBusinessDICK’S Sporting Goods’ guidance cut rattles NIKE, highlighting how weakness at a key specialty retailer can spreadThe Apex TimesBusinessBroadcom (AVGO) set to report earnings Wednesday after the bell, with investors focused on guidance and demand outlinesThe Apex TimesBusinessApple’s John Ternus steps in as investors weigh a valuation-driven “nearly $5 trillion” challengeThe Apex TimesBusinessSalesforce shares jump 22% after results challenge AI skepticism, CNBC’s Jim Cramer saysThe Apex TimesBusinessSeasonality on Wall Street turns investors’ attention to September, with Nvidia and Micron in focusThe Apex TimesBusinessJim Cramer argues Netflix’s valuation should reflect durability despite leadership shake-upThe Apex TimesBusinessNetflix releases a new trailer and key art for ‘The Fixers,’ previewing covert missions in Taiwan’s temple worldThe Apex TimesBusinessLilly’s $2.88 Billion Immunology Acquisition Moves Into Phase 1 as Lead Program Remains EarlyThe Apex TimesBusinessNvidia’s $3.5 Billion Push Highlights a Broader AI Supply-Chain StrategyThe Apex TimesBusinessTesla shares rise after unveiling a cheaper Model 3 in Hong KongThe Apex TimesBusinessAnthropic signs a $35 billion cloud computing deal tied to Nvidia-backed startupThe Apex TimesBusinessIntel’s push toward on-prem, privacy-focused AI gets a partnership spotlight as Xeon 6 platform work expandsThe Apex TimesBusinessDICK’S Sporting Goods’ guidance cut rattles NIKE, highlighting how weakness at a key specialty retailer can spreadThe Apex TimesBusinessBroadcom (AVGO) set to report earnings Wednesday after the bell, with investors focused on guidance and demand outlinesThe Apex TimesBusinessApple’s John Ternus steps in as investors weigh a valuation-driven “nearly $5 trillion” challengeThe Apex TimesBusinessSalesforce shares jump 22% after results challenge AI skepticism, CNBC’s Jim Cramer saysThe Apex TimesBusinessSeasonality on Wall Street turns investors’ attention to September, with Nvidia and Micron in focusThe Apex TimesBusinessJim Cramer argues Netflix’s valuation should reflect durability despite leadership shake-upThe Apex TimesBusinessNetflix releases a new trailer and key art for ‘The Fixers,’ previewing covert missions in Taiwan’s temple worldThe Apex TimesBusinessLilly’s $2.88 Billion Immunology Acquisition Moves Into Phase 1 as Lead Program Remains EarlyThe Apex TimesBusinessNvidia’s $3.5 Billion Push Highlights a Broader AI Supply-Chain StrategyThe Apex TimesBusinessTesla shares rise after unveiling a cheaper Model 3 in Hong KongThe Apex TimesBusinessAnthropic signs a $35 billion cloud computing deal tied to Nvidia-backed startupThe Apex Times
Back to front
UBS reiterates a Buy on Palantir after the stock’s slump, maintaining a $200 price target
The Apex Times

THE APEX TIMES

Business/The Apex Times/Jun 20, 8:35 AM EDT

UBS reiterates a Buy on Palantir after the stock’s slump, maintaining a $200 price target

A fresh analyst check published June 16 keeps Palantir Technologies in the Buy camp, arguing the company remains investable despite recent weakness in the share price.

Palantir Technologies Inc. (PLTR) was the subject of renewed analyst attention after its shares fell, with UBS reiterating a Buy rating in a June 16 note highlighted in market coverage on June 20.

According to the article, UBS affirmed its positive view and maintained a $200 price target. A price target is the analyst’s estimate of where the stock could trade over an identified time horizon, and it typically reflects assumptions about growth and valuation.

The coverage frames Palantir as a “falling stock” opportunity, a description tied to the idea that recent declines can create a less favorable entry price for investors who believe fundamentals and future results will hold up.

UBS’s action is significant mainly because analyst rating changes often reflect a judgment about risk and upside rather than only short-term trading. In this case, the reiteration suggests UBS did not view the stock’s drop as enough to remove Palantir from its higher-conviction category.

For Palantir, the market has often focused on whether the company can sustain momentum across its major customer segments and product deployments. However, the article does not provide detailed updates on customer wins, contract size, or operating metrics in the information available here.

The limited disclosure in the market coverage also leaves unanswered what specifically prompted UBS to revisit the name at that time. The write-up, as provided, does not detail any new financial guidance, changes in assumptions, or particular developments in Palantir’s pipeline or backlog.

In the absence of additional detail from the article, investors and readers may want to look beyond the rating recap to see whether UBS’s note was driven by valuation, revisions to estimates, or expectations about timing of future revenue recognition. Those components are usually central to how a target price stays the same or moves up.

Going forward, attention will likely remain on whether Palantir can translate demand for its analytics and software deployments into consistent, measurable results. The next inflection point for the stock will likely be any company commentary in earnings and any further analyst updates that either sustain or recalibrate the $200 target.

Why It Matters

  • A reiterated Buy with an unchanged price target can announcement that the analyst sees the stock decline as an opportunity rather than a fundamental deterioration.
  • Maintained target levels can also reflect a valuation-based view, where near-term price weakness is not believed to change the longer-term earnings outlook.
  • For shareholders, new analyst color can influence sentiment, even when it does not change the company’s disclosed fundamentals.
  • Because the available coverage does not include the rationale, investors may need to monitor subsequent filings and earnings to understand whether the underwriting assumptions are playing out.

Sources

Key Facts

  • Market coverage highlighted a June 20 report referencing a June 16 analyst note from UBS on Palantir Technologies (PLTR).
  • UBS reiterated a Buy rating on Palantir.
  • UBS maintained a $200 price target for Palantir, as described in the coverage.
  • The coverage characterizes Palantir as a “falling stock,” linking the positive rating to the recent decline in the shares.
  • No additional operational or financial specifics beyond the rating and target were included in the material available here.

Technology Related

Aug 31, 11:21 PM EDT
The Apex Times

Salesforce shares jump 22% after results challenge AI skepticism, CNBC’s Jim Cramer says

Salesforce reported fiscal second-quarter 2027 results on Aug. 27, sending its stock up about 22.6% as investors reassessed worries that artificial intelligence would undercut demand for enterprise software. Jim Cramer, speaking in a market context reported by Yahoo Finance, argued those AI fears were overblown.

Salesforce shares jump 22% after results challenge AI skepticism, CNBC’s Jim Cramer says
The Apex Times
UBS reiterates a Buy on Palantir after the stock’s slump, maintaining a $200 price target | The Apex Times